Mirae Asset Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 30-10-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI -2.73 9.07 47.95 11.20 1.92 14.09
S&P BSE SENSEX - TRI 4.25 5.31 0.09 7.29 9.62 12.63

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 50.40 18.51 7.18 2.19 3,910.67
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 51.47 11.49 2.54 2.47 1,433.75
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 55.00 14.40 4.66 2.79 585.98

Fund Holdings as on 30-September-2020

  • Dr. Reddy's Laboratories Limited

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • Cipla Limited

  • IPCA Laboratories Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Laurus Labs Limited

  • Apollo Hospitals Enterprise Limited

  • Biocon Limited

  • Dr. Lal Path Labs Limited

  • Ajanta Pharma Limited

  • Abbott India Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Net Receivables / (Payables)

  • Natco Pharma Limited

  • Syngene International Limited

  • Vinati Organics Limited

  • Rossari Biotech Limited

  • Max Financial Services Limited

  • Sanofi India Limited

  • Alkem Laboratories Limited

  • SBI Life Insurance Company Limited

  • SRF Limited

  • HDFC Life Insurance Company Limited

  • Tri Party Repo

  • Neogen Chemicals Limited

  • Chemcon Speciality Chemicals Limited

  • Mirae Asset Cash Management Fund - DIRECT GROWTH

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Miscellaneous

  • Insurance

  • Finance - Others

  • Diversified

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About Mirae Asset Healthcare Fund

Scheme Analysis

Mirae Asset Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Mirae Asset Mutual Fund. It was launched on 02-Jul-2018 and currently has an AUM of ₹1,006.15 crore. Mirae Asset Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of Mirae Asset Healthcare Fund ended down ₹-0.02(-0.12%)yesterday to ₹17.013.

Among its top 3 holdings the fund has exposure to Dr. Reddy's Laboratories Limited, and

The Mirae Asset Healthcare Fund is managed by Vrijesh Kasera .

Fund House Contact

Unit 606, 6th Floor, Windsor, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098

022-67800300
022-67253942